APPENDIX G. INSTRUCTIONS FOR PREPARING OCCUPATIONAL EXPOSURE DATA FOR SUBMITTAL TO THE RADIATION EXPOSURE MONITORING SYSTEM (REMS) REPOSITORY

1. TRANSMITTAL LETTER

A transmittal letter containing the following information at a minimum will accompany each submittal to the REMS repository.

The exposure data file is to be error checked using the latest version of the REMSView program provided by the REMS repository and all reported errors resolved prior to transmitting the file to REMS. REMSView may be obtained from the DOE REMS Project Manager, or online at http://www.hss.energy.gov/csa/csp/rems/.

2. MEDIA REQUIREMENTS

Data will be submitted to REMS via electronic media. The default electronic media for exposure data is a CD or an IBM compatible 3.5-inch diskette, 1.44 MB formatted capacity. Other magnetic media are acceptable, but must be approved by the DOE REMS Project Manager prior to submission. The data file may be compressed on the electronic media as long as instructions and required software needed to extract the data file are provided. Alternative methods of electronic submission may be accommodated if approved in advance by the DOE REMS Project Manager.

a. File Structure.

Each data record is to be of a fixed length. Extra spaces in the field should be padded with blanks. Do not use nulls (ASCII character 0), or tabs, or any other non-printable characters in any record. Terminate each record with a carriage return and line feed. Responses are required to all fields unless otherwise noted.

3. INSTRUCTIONS FOR PREPARING ELECTRONIC OCCUPATIONAL EXPOSURE DATA SUBMITTALS

Individual exposure data records required to be reported to the Radiation Records Repository will be formatted as shown in Table G-1.

Table G-1. Electronic Data Submittals
# Data Element Example Code or Data Field Size Column Range Instructions
1 Monitoring Year 2008 4 1-4 Enter the year for which the monitoring results are being submitted. The monitoring year, as defined in 10 CFR 835.2 may differ slightly from the calendar year due to dosimetry processing schedules.
2 Organization Code 1234567 7 5-11 7-digit organization code, available from the repository. Whenever possible, the appropriate CAIRS organization code should be used. See Appendix E (2).
3 Facility Code LAB #12 15 12-26 The code representing the facility where the dose was received for the personnel exposure records. Organizations may determine the Facility Code using printable ASCII characters of 15 characters or less. The Facility Code assigned should remain consistent from year to year.
4 Facility Type Code 61 2 27-28 See Facility Type codes, Table G-4
5 Phase of Operation C 1 29 See Phase of Operation codes, Table G-5
6 ID Number 123456789 15 30-44 The identification number for this individual.
7 ID Type SSN 3 45-47 The type of identification number used to identify the individual. See ID Type codes Table G-6.
8 First Name Mary 30 48-77 Legal first name or initial
9 Middle Name Q 20 78-97 Middle name or initial
10 Last Name Public 30 98-127 Last name including title
11 Birth Date 19660101 8 128-135 Date of birth of individual (YYYYMMDD)
12 Sex F 1 136 Sex of the monitored individuals
13 Occupation Code 184 3 137-139 See Occupation Codes, Tables G-7
14 Monitoring Status E 1 140
  • E General Employee, employee of the reporting organization, visiting researcher, or student
  • P Member of the Public, including visiting dignitaries
  • G Special Individuals as defined in Chapter III, paragraph 1b(1)
15 Exposure Type R 1 141
  • R Routine
  • P PSE, Planned Special Exposure
  • E Emergency, exposure that occurred during an emergency when emergency dose limits and procedures were in effect
16 Monitoring Start Date 20080101 8 142-149 Date monitoring began for the reporting year (YYYYMMDD)
17 Monitoring End Date 20081231 8 150-157 Date monitoring ended for the reporting year (YYYYMMDD)
18 Effective Dose (ED) 120 7 158-164 The effective dose at 1.0 cm depth from external radiation sources, including neutron radiation in millirem. monitoring should be conducted in accordance with the guidance provided in the external dosimetry chapter of DOE G 441.1-1C Implementation Guide for Use with Title 10, CFR, Part 835, Occupational Radiation Protection, dated 2008. If monitoring is not provided, the field >should be blank (padded with spaces). Enter NM as the associated measurement code.
19 Effective Dose Measurement Code MV 2 165-166 Measurement code for the dose value. See Measurement Codes, Table G-8.
20 Effective Dose from Neutron (ED - neutron) 20 7 167-173 The effective dose at 1.0 cm depth from neutron radiation in millirem. Monitoring should be conducted in accordance with the guidance provided in the external dosimetry chapter of DOE G 441.1-1C Implementation Guide for Use with Title 10, CFR, Part 835, Occupational Radiation Protection, dated 2008. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code.
21 Neutron Dose Measurement Code MV 2 174-175 Measurement code for the neutron dose value. See Measurement Codes, Table G-8.
22 Equivalent Dose to the Lens of the Eye (EqD - Eye) (blank, padded with spaces) 7 176-182 Equivalent Dose to the lens of the eye at a tissue depth of 0.3 cm in millirem, including the whole body dose from neutron radiation in millirem. monitoring should be conducted in accordance with the guidance provided in DOE G 441.1-1C. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code.
23 Lens of the eye Dose Measurement Code NM 2 183-184 Measurement code for the eye dose value. See Measurement Codes, Table G-8.
24 External Equivalent Dose to the skin of the Whole Body (EqD - SkWB)1 120 7 185-191 Equivalent Dose from external radiation at a depth of 0.007 cm to the skin of the whole body, including the neutron dose in millirem. monitoring should be conducted in accordance with the guidance provided in DOE G 441.1-1C. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code. This includes assessment of skin dose from non-uniform exposure of the skin required by 10 CFR 835.205(b). Per 10 CFR 835.702(b), recording of non-uniform equivalent dose is not required if the dose is less than 1 rem.
25 Skin Dose (WB) Measurement Code MV 2 192-193 Measurement code for the skin dose (WB) value. See Measurement Codes, Table G-8.
26 External Equivalent Dose to the Skin, Upper Right Extremity (EqD - UR)1 120 7 194-200 Equivalent Dose from external radiation at a depth of 0.007 cm to the upper right extremity (e.g., right hand), including the neutron dose in millirem. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code. This includes assessment of skin dose from non-uniform exposure of the skin required by 10 CFR 835.205(b). Per 10 CFR 835.702(b), recording of non-uniform equivalent dose is not required if the dose is less than 1 rem.
27 Skin - UR Measurement Code MV 2 201-202 Measurement code for the Skin - UR value. See Measurement Codes, Table G-8.
28 External Equivalent Dose to the Skin, Upper Left Extremity (EqD - UL)1 150 7 203-209 Equivalent Dose from external radiation at a depth of 0.007 cm to the upper left extremity (e.g., left hand), including the neutron dose in millirem. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code. This includes assessment of skin dose from non-uniform exposure of the skin required by 10 CFR 835.205(b). Per 10 CFR 835.702(b), recording of non-uniform equivalent dose is not required if the dose is less than 1 rem.
29 Skin - UL Measurement Code MV 2 210-211 Measurement code for the skin - UL value. See Measurement Codes, Table G-8.
30 External Equivalent Dose to the Skin, Lower Right Extremity (EqD - LR)1 (blank, padded with spaces) 7 212-218 Equivalent Dose from external radiation at a depth of 0.007 cm to the lower right extremity (i.e., right foot, ankle, or lower leg), including the neutron dose in millirem. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code. This includes assessment of skin dose from non-uniform exposure of the skin required by 10 CFR 835.205(b). Per 10 CFR 835.702(b), recording of non-uniform equivalent dose is not required if the dose is less than 1 rem.
31 Skin - LR Measurement Code NM 2 219-220 Measurement code for the skin - LR value. See Measurement Codes, Table G-8.
32 External Equivalent Dose to the Skin, Lower Left Extremity (EqD - LL)1 (blank, padded with spaces) 7 221-227 Equivalent Dose from external radiation at a depth of 0.007 cm to the lower left extremity (i.e., left foot, ankle, or lower leg), including the neutron dose in millirem. If monitoring is not provided, the field should be blank (padded with spaces) and 'NM' should be entered as the associated measurement code. This includes assessment of skin dose from non-uniform exposure of the skin required by 10 CFR 835.205(b). Per 10 CFR 835.702(b), recording of non-uniform equivalent dose is not required if the dose is less than 1 rem.
33 Skin - LL Measurement Code NM 2 228-229 Measurement code for the skin - LL value. See Measurement Codes, Table G-8.
34 Committed Effective Dose (CED) 241 7 230-236 The 50-year CED from intakes during the monitoring period in millirem.
35 CED Measurement Code MV 2 237-238 Measurement code for the CED value. See Measurement Codes, Table G-8
36 Radionuclide 1 PU238 7 239-245 The scientific abbreviation of the radionuclide taken into the body that contributed to the internal dose. Use the standard scientific format of 'Xx999x', where 'X' represents an alphanumeric and '9' represents a numeric character. List only the six highest contributors among the following fields. Enter only one radionuclide per field. Do not include daughter products. When possible, list the radionuclides in descending order of their contribution to the internal dose.
37 Radionuclide 2 (blank padded with spaces) 7 246-252 The scientific abbreviation of the second radionuclide taken into the body.
38 Radionuclide 3 (blank padded with spaces) 7 253-259 The scientific abbreviation of the third radionuclide taken into the body.
39 Radionuclide 4 (blank padded with spaces) 7 260-266 The scientific abbreviation of the fourth radionuclide taken into the body.
40 Radionuclide 5 (blank padded with spaces) 7 267-273 The scientific abbreviation of the fifth radionuclide taken into the body.
41 Radionuclide 6 (blank padded with spaces) 7 274-280 The scientific abbreviation of the sixth radionuclide taken into the body.
42 Committed Equivalent Dose to the gonads(CEqD - GO) 97 7 281-287 The 50-year Committed Equivalent Dose to the gonads from the intake of the radionuclides for this monitoring period, in millirem.
43 Committed Equivalent Dose to the breasts(CEqD - BR) 13 7 288-294 The 50-year Committed Equivalent Dose to the breasts from the intake of the radionuclides for this monitoring period, in millirem.
44 Committed Equivalent Dose to the red bone marrow(CEqD - BM) 359 7 295-301 The 50-year Committed Equivalent Dose to the red bone marrow from the intake of the radionuclides for this monitoring period, in millirem.
45 Committed Equivalent Dose to the lungs(CEqD - LU) 189 7 302-308 The 50-year Committed Equivalent Dose to the lungs from the intake of the radionuclides for this monitoring period, in millirem.
46 Committed Equivalent Dose to the thyroid(CEqD - TH) 13 7 309-315 The 50-year Committed Equivalent Dose to the thyroid from the intake of the radionuclides for this monitoring period, in millirem.
47 Committed Equivalent Dose to the bone surface(CEqD - BS) 7260 7 316-322 The 50-year Committed Equivalent Dose to the bone surface from the intake of the radionuclides for this monitoring period, in millirem.
48 Committed Equivalent Dose to the colon (CEqD - CO) 13 7 323-329 The 50-year Committed Equivalent Dose to the colon from the intake of the radionuclides for this monitoring period, in millirem.
49 Committed Equivalent Dose to the stomach (CEqD - ST) 13 7 330-336 The 50-year Committed Equivalent Dose to the stomach from the intake of the radionuclides for this monitoring period, in millirem.
50 Committed Equivalent Dose to the bladder (CEqD - BL) 13 7 337-343 The 50-year Committed Equivalent Dose to the bladder from the intake of the radionuclides for this monitoring period, in millirem.
51 Committed Equivalent Dose to the liver (CEqD - LV) 1530 7 344-350 The 50-year Committed Equivalent Dose to the liver from the intake of the radionuclides for this monitoring period, in millirem.
52 Committed Equivalent Dose to the esophagus (CEqD - ES) 13 7 351-357 The 50-year Committed Equivalent Dose to the esophagus from the intake of the radionuclides for this monitoring period, in millirem.
53 Committed Equivalent Dose to the skin (CEqD - SK) 13 7 358-364 The 50-year Committed Equivalent Dose to the skin from the intake of the radionuclides for this monitoring period, in millirem.
54 Committed Equivalent Dose to the remainder (CEqD - RE) 1608 7 365-371 The 50-year Committed Equivalent Dose to the remainder from the intake of the radionuclides for this monitoring period, in millirem.
55 Total Effective Dose (TED) 361 7 372-378 The sum of the Effective Dose and the Committed Effective Dose in millirem.
56 Total Organ Dose (TOD) 7380 7 379-385 The sum of the Effective Dose and the Committed Equivalent Dose to the maximally exposed organ in millirem.
57 Equivalent Dose to the Embryo/Fetus (EqD - Fetus) (blank padded with spaces) 7 386-392 Equivalent Dose to the embryo/ fetus during the pregnancy from conception to the end of the pregnancy, in millirem. Dose determination should be made in accordance with DOE G 441.1-1C.
58 Comment Text Further information for this dose record is contained in the Occurrence Report # 140 393-532 Text of the comment applicable to the dose record in the data file. Comments should be limited to information needed to assess the record, such as references to additional documentation concerning the record. If no comments are necessary, the record may be terminated with a carriage return and line feed at column 346 with one space entered for the comment.

1 Although not reported to REMs, compliance with the occupational dose limits specified in 10 CFR 835.202(a)(4) requires summation of the equivalent dose to the skin or to any extremity (i.e. data elements 24, 26, 28, 30 and 32) with the committed equivalent dose to the skin or to any extremity (i.e. data element 53). REMs will sum these data elements.

4. OCCUPATIONAL EXPOSURE DATA SUMMARY EXPLANATION.

Policies and procedures should be in place to ensure that duplicate monitoring results for an individual are not reported to the repository by more than one organization.

All equivalent doses will be in units of millirem, rounded to the nearest whole number and right justified within the appropriate field. If monitoring was not provided for a specific dose value, do not enter a value. Leave the field blank, padded with spaces, and enter NM in the corresponding measurement code field.

Occupational exposure monitoring should be provided in accordance with the guidance provided in the following DOE documents: DOE G441.1-C.

Dose records for more than one facility are required only where radiation monitoring is performed and recorded for specific facilities. If only site-wide monitoring is provided, only one facility record code should be included in the submittal to represent the entire site. For individuals receiving dose at multiple facilities where the fraction of dose received at each facility code cannot be determined, the entire dose should be attributed to the facility where the majority of dose was received. If the facility where the majority of dose was received cannot be determined, the facility code where the individual spent the majority of the monitoring period should be used.

Comment records are required only if additional information is needed to assess the record.

Reporting of fetal exposure data is required for a declared pregnant worker. Fetal exposure data should be included in the submittal for the monitoring year that encompasses the pregnancy end date.

5. BIOASSAY AND INTAKE SUMMARY FILE EXPLANATION.

The following files must be submitted as separate ASCII files containing annual summary records for bioassay and intake information. These files should be submitted on the same media as the annual submittal as shown in Tables G-2 and G-3 respectively. The Bioassay Summary file should contain one record for each facility. The Intake Summary file should contain one record for each facility, radionuclide, and intake mode.

Bioassay Summary records are required to be reported when any individual participates in a bioassay program or in vivo monitoring during the monitoring year.

Intake Summary records are required to be reported when any individual has received a dose from intakes during the monitoring year. Monitoring results corresponding to doses not exceeding the thresholds listed in 10 CFR 835.702(b) need not be reported.

Table G-2. Bioassay Summary File
# Data Element Example Code or Data Field Size Column Range Instructions
1 Facility
Code
LAB #12 15 1-15

The code representing the facility where the dose was received for the personnel exposure records. Organizations may determine the Facility Code using printable ASCII characters of 15 characters or less. The Facility Code assigned should remain consistent from year to year.

2 Monitoring Year 2008 4 16-19

Enter the year for which the monitoring records are being submitted. The monitoring year, as defined in 10 CFR 835.2 may differ slightly from the calendar year due to dosimetry processing schedules.

3 Total 237 5 20-24

Total number of individuals monitored in the bioassay program or in vivo monitoring during the year.

4 Routine 233 5 25-29

Number of routine bioassay performed during the year.

5 Special 4 5 30-34

Number of special bioassay or in vivo measurements performed during the year.

6 Urinalysis 212 5 35-39

Number of urine samples analyzed during the year.

7 Fecal 32 5 40-44

Number of fecal samples analyzed during the year.

8 In Vivo 120 5 45-49

Number of in vivo measurements performed excluding wound counts during the year.

9 Wound 3 5 50-54

Number of in vivo measurements performed on wounds during the year.

10 Other 1 5 55-59

Number of other measurements performed in order to determine internal dose for an individual during the year (e.g., air sampling or other method).

Table G-3. Intake Summary File
# Data Element Example Code or Data Field Size Column Range Instructions
1 Facility Code LAB# 12 15 1-15 The code representing the facility where the dose was received for the personnel exposure records. Organizations may determine the Facility Code using printable ASCII characters of 15 characters or less. The Facility Code assigned should remain consistent from year to year.
2 Monitoring Year 2008 4 16-19 Enter the year for which the monitoring results are being submitted. The Monitoring Year as defined in 10 CFR 835.2 may differ slightly from the calendar year due to dosimetry processing schedules.
3 Radionuclide Pu238 7 20-26 The scientific abbreviation of the radionuclide taken into the body. Use the standard scientific format of 'Xx999x', where 'X' represents an alphanumeric and '9' represents a numeric character. Enter only one radionuclide per record. Do not include daughter products or radionuclides that did not result in internal doses during the monitoring year.
4 Mode W 1 27 Mode of the intake.
  • H = Inhalation (record tritiated water intakes as inhalations.)
  • G = Ingestion
  • A = Absorption
  • W = Wound, cut, puncture, injection or any other intake through broken skin.
5 Collective CED 3489 7 28-34 The collective 50-years CED from intakes of this radionuclide and intake mode during the monitoring year, in millirem.

6. FACILITY TYPE CODES.

The facility record should identify the facility type where the worker's doses were received. The facility type should reflect the original function of the facility even if activities in support of that function are no longer being conducted at the facility. Facility type codes are listed in Table G-4.

Tables G-4 through G-8 list codes used in filling out occupational exposure records.

Table G-4. Facility Type Codes.
Facility Type Code Facility Type Description
>10 Accelerator
21 Fuel/Uranium Enrichment
22

Fuel Fabrication
23

Fuel Processing
40 Maintenance and Support (site-wide)
50 Reactor
61 Research, General
62 Research, Fusion
70 Waste Processing/Management
80 Weapons Fabrication and Testing
99 Other

7. FACILITY PHASE OF OPERATION CODES.

The phase of operation will be recorded for the calendar year for which the phase of operation is most appropriate. For facilities that transition between phases during a year, the phase that is appropriate for the majority of the calendar year should be recorded. Each DOE facility falls into one of the Phase of Operations shown in Table G-5. In general, each phase follows in sequential order, although a facility may forgo one or more phases or may not follow the order listed here.

Table G-5. Facility Phase of Operation Codes.
Code Phase of Operation Definition
A

Construction (includes Major Renovation)

New facilities that are brought on line to replace or augment existing facilities. This phase includes major renovations for existing facilities but does not include environmental restoration construction.
B Operations/Maintenance Includes the normal, mission-related operations and maintenance of the reported Facility Type.
C Stabilization Facilities that have been declared to be surplus (assigned to the environmental restoration program). This includes facilities where all operations have been suspended but environmental restoration activities have not begun. This may include periods of surveillance and maintenance prior to environmental restoration activities.
D Remediation Period during which corrective actions that are necessary to bring the facility into regulatory compliance are being performed.
E Decontamination and Decommissioning Decontamination is the act of removing a chemical, biological, or radiological contaminant from, or neutralizing its potential effect on, a person, object, or environment by washing, chemical action, mechanical cleaning, or other techniques. Decommissioning is the process of closing and securing a facility.
F Waste Management This phase includes the management of wastes generated during the environmental restoration process.
G Surveillance and Maintenance This phase includes those activities that provide for the safety and protection of a facility after the environmental restoration phase.
Z Other All DOE facilities should fit into one of the above categories. 'Other' should be used only in highly unusual circumstance.
Table G-6. Identification Codes.
ID Type Code Identification Type Description

SSN

U.S. Social Security Number
PPN Passport Number
CSI Canadian Social Insurance Number
WPN Work Permit Number
OTH Other
1 Other identification numbers are unique identifiers assigned by the reporting organization when all other identification types are unavailable. The individual's SSN should be used whenever possible. The first 7 digits of an 'other' identification number must be the organization code for the reporting organization. The remaining 8 digits of the ID number should be unique for each individual being submitted by the reporting organization.
Table G-7. Occupational Codes.
DOE Code DOE Occupational Categories Cross-Reference SOC Code (ranges)1
1 UNKNOWN
110 MANAGERS AND ADMINISTRATORS 11-14
PROFESSIONAL 15-39
160 Engineers 16
170 Scientists 17-19
184 Health Physicists 1843
200 Miscellaneous Professionals 20-25, 32-34
260 Doctors and Nurses 26-30
350 Technicians 35-39
360 Health Technicians 36
370 Engineering Technicians 37
380 Science Technicians 38
383 Radiation Monitors/Technicians 383
390 Miscellaneous Technicians 39
400 SALES 40-44
450 ADMINISTRATIVE SUPPORT AND CLERICAL 45-47
SERVICE WORKERS 50-52
512 Firefighters 512
513 Protective Force 513/4
521 Food Service Employees 521
524 Janitors 524
525 Miscellaneous Service Employees 523, 525/6
AGRICULTURAL WORKERS 55-58
562 Grounds keeper 562
570 ForestWorkers 57
580 Miscellaneous Agricultural Workers 55, 561, 58
REPAIR/CONSTRUCTION WORKERS 60-65
610 Mechanics/Repairers 60-61
641 Masons 641
642 Carpenters 642
643 Electricians 643
644 Painters 644
645 Pipe Fitters 645
650 Miners/Drillers 65
660 Miscellaneous Repairers/Construction Workers 63, 646
PRECISION/PRODUCTION WORKERS 67-78
681 Machinists 681
682 Sheet Metal Workers 682
690 Operators, Plant/System/Utility 69
710 Machine Setup/Operators 71-76
771 Welders and Solderers 771
780 Miscellaneous Precision/Production Workers 67, 683-688, 722-78
TRANSPORT WORKERS 81-83
820 Truck Drivers 8212-8214
821 Bus Drivers 8215
825 Pilots 825
830 Equipment Operators 83
840 Miscellaneous Transporters 81, 8216-824, 828
850 HANDLERS/LABORERS/HELPERS 85-87
910 MILITARY PERSONNEL 91
990 MISCELLANEOUS WORKERS 99

1Refers to the Department of Commerce's Standard Occupational Classification (SOC) Manual (1980).

Table G-8. Dose Measurement Codes.
Code Meaning Definition
MV Measured Value Indicates that measurements were performed for the specific individual to determine the dose for that individual. This measurement code would apply in all cases where individual external dosimetry was used or where the individual participated in a bioassay program (including whole body or lung count) that was used to determine the individual's internal dose.
PV Preliminary Value Indicates that this measurement is an interim estimation and expects to be updated in a subsequent revision and submittal of this dose record. This measurement code should be used when the final dosimetry or bioassay results are not yet available but the submittal is due.
CV Calculated Value Indicates the value given was calculated from indirect measurements such as monitoring performed on other workers or determined from a time-motion study or other analysis such as air sample for internal exposures. The value given represents the final results of the calculation, but the value was not measured directly for the monitored individual. A comment record may be provided to explain the reason and method of calculation.
NM Not Monitored Dosimetry was not provided and was not required to be provided.
ND Not Detectable Monitoring was performed but the results were below the detection limit of the measurement instrumentation.